HFA Premium Access

Association of Baseline Cardiac Biomarkers on Clinical Outcomes and Vericiguat Treatment Effect in Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Presentation

About the speaker

Associate Professor Christopher DeFilippi

University of Maryland, Baltimore (United States of America)
2 presentations
0 follower

13 more presentations in this session

Omecamtiv Mecarbil in Patients with Severe Heart Failure: An Analysis from Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF)

Speaker: Professor G. Felker (Durham, US)

Thumbnail

Efficacy and Safety of Antithrombotic Strategies in Patients With Atrial Fibrillation and Recent ACS or PCI With and Without A History of Heart Failure: Insights From the AUGUSTUS Trial

Speaker: Doctor M. Fudim (Durham, US)

Thumbnail

Nurse Intervention for Less Chronic Heart Failure Study

Speaker: Professor S. Stewart (Adelaide, AU)

Thumbnail

Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial.

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

Telemedical Interventional Management in Heart Failure

Speaker: Professor F. Koehler (Berlin, DE)

Thumbnail

Access the full session

Clinical Trial Updates

Speakers: Associate Professor C. DeFilippi, Professor G. Felker, Doctor M. Fudim, Professor S. Stewart, Professor J. McMurray...
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

ESC Premium Access

New and upcoming technology for heart failure management.

23 October 2021

ESC Premium Access

MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

28 August 2021

ESC Premium Access

Refining dual antithrombotic treatment in patients with chronic coronary syndrome

27 August 2021

This platform is supported by

logo Novo Nordisk